Walgreens Updates: Analyst Ratings and Earnings Forecasts Today
Walgreens Prepares for Fourth Quarter Earnings Release
Walgreens Boots Alliance, Inc. WBA is gearing up to unveil its earnings results for the fourth quarter. This event is anticipated as it provides valuable insights into the company's financial performance.
Earnings Projections and Revenue Estimates
Analysts have an intriguing outlook for Walgreens. It is expected that the company will report earnings of 36 cents per share, significantly lower than the 67 cents per share recorded in the previous year. Notably, Walgreens projects revenue around $35.75 billion, a slight increase from $35.42 billion in the same quarter last year.
Walgreens Stock Performance
Recently, Walgreens shares experienced a decline, dropping about 2.3% to close at $9.00, reflecting the current market sentiment regarding the stock.
Analyst Ratings and Price Targets
As Walgreens approaches its earnings announcement, let’s take a closer look at how analysts perceive the stock:
- Morgan Stanley analyst Erin Wright has opted to maintain an Underweight rating while reducing the price target from $9 to $7, signaling cautious sentiment.
- Truist Securities analyst David Macdonald also maintained a Hold rating, decreasing the price target from $13 to $10, reflecting a moderate approach to the stock.
- UBS analyst Kevin Caliendo kept a Neutral rating but revised the price target down from $17 to $12, suggesting the possibility of stabilizing earnings.
- RBC Capital analyst Ben Hendrix noted a Sector Perform rating with a revised price target adjustment from $22 to $13.
- Deutsche Bank analyst Scott George Hill maintained a Hold rating and slightly lowered the price target from $23 to $22.
What’s Next for WBA?
If you're considering an investment in WBA stock, keep an eye on the analysts’ predictions and market movements as the company prepares to disclose its financial outcomes. Understanding varying analyst perspectives can provide a more comprehensive view of the potential investment landscape.
Frequently Asked Questions
What are the expected earnings for Walgreens in Q4?
Analysts expect Walgreens to report earnings of 36 cents per share for the fourth quarter.
What has caused Walgreens' stock to drop recently?
The stock fell 2.3% to close at $9.00, reflecting uncertainties in the market regarding its performance.
How do recent analyst ratings impact Walgreens' stock?
Analyst ratings can influence investor sentiment and stock performance, guiding trading strategies and investment decisions.
What is the revenue projection for Walgreens in Q4?
Walgreens anticipates quarterly revenue of approximately $35.75 billion.
How should investors approach Walgreens stock currently?
Investors should assess analyst ratings and expectations while considering their investment goals and market conditions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.